<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="acn370013" xml:lang="en" article-type="brief-report"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Clin Transl Neurol</journal-id><journal-id journal-id-type="iso-abbrev">Ann Clin Transl Neurol</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2328-9503</journal-id><journal-id journal-id-type="publisher-id">ACN3</journal-id><journal-title-group><journal-title>Annals of Clinical and Translational Neurology</journal-title></journal-title-group><issn pub-type="epub">2328-9503</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40146714</article-id><article-id pub-id-type="pmc">PMC12093331</article-id>
<article-id pub-id-type="doi">10.1002/acn3.70013</article-id><article-id pub-id-type="publisher-id">ACN370013</article-id><article-id pub-id-type="other">ACN3-2024-11-1245-BC.R1</article-id><article-categories><subj-group subj-group-type="overline"><subject>Brief Communication</subject></subj-group><subj-group subj-group-type="heading"><subject>Brief Communication</subject></subj-group></article-categories><title-group><article-title>Novel Phenotypes and Deep Intronic Variant Expand <styled-content style="fixed-case" toggle="no">TH</styled-content>&#x02010;Associated Dopa&#x02010;Responsive Dystonia Spectrum</article-title></title-group><contrib-group><contrib id="acn370013-cr-0001" contrib-type="author"><name><surname>Zheng</surname><given-names>Xiaosheng</given-names></name><xref rid="acn370013-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="acn370013-cr-0002" contrib-type="author"><name><surname>Ying</surname><given-names>Chenxin</given-names></name><xref rid="acn370013-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="acn370013-cr-0003" contrib-type="author"><name><surname>Jin</surname><given-names>Nan</given-names></name><xref rid="acn370013-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="acn370013-cr-0004" contrib-type="author"><name><surname>Ma</surname><given-names>Jinghong</given-names></name><xref rid="acn370013-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="acn370013-cr-0005" contrib-type="author"><name><surname>Wan</surname><given-names>Xinhua</given-names></name><xref rid="acn370013-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="acn370013-cr-0006" contrib-type="author"><name><surname>Li</surname><given-names>Xunhua</given-names></name><xref rid="acn370013-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="acn370013-cr-0007" contrib-type="author" corresp="yes"><name><surname>Luo</surname><given-names>Wei</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6951-7698</contrib-id><xref rid="acn370013-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>luoweirock@zju.edu.cn</email></address></contrib></contrib-group><aff id="acn370013-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<institution>The Second Affiliated Hospital, Zhejiang University School of Medicine</institution>
<city>Hangzhou</city>
<named-content content-type="country-part">Zhejiang</named-content>
<country country="CN">China</country>
</aff><aff id="acn370013-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<institution>Xuanwu Hospital of Capital Medical University</institution>
<city>Beijing</city>
<country country="CN">China</country>
</aff><aff id="acn370013-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<institution>Peking Union Medical College Hospital</institution>
<city>Beijing</city>
<country country="CN">China</country>
</aff><aff id="acn370013-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Neurology Department</named-content>
<institution>The First Affiliated Hospital, Sun&#x02010;Yet Sen University</institution>
<city>Guangzhou</city>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold>
<break/>
Wei Luo (<email>luoweirock@zju.edu.cn</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>3</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2025</year></pub-date><volume>12</volume><issue seq="220">5</issue><issue-id pub-id-type="doi">10.1002/acn3.v12.5</issue-id><fpage>1093</fpage><lpage>1096</lpage><history>
<date date-type="rev-recd"><day>09</day><month>1</month><year>2025</year></date>
<date date-type="received"><day>20</day><month>11</month><year>2024</year></date>
<date date-type="accepted"><day>28</day><month>1</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 American Neurological Association--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Annals of Clinical and Translational Neurology</italic> published by Wiley Periodicals LLC on behalf of American Neurological Association.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:ACN3-12-1093.pdf"/><abstract><title>ABSTRACT</title><p>Approximately 20% of dopa&#x02010;responsive dystonia (DRD) cases remain genetically unresolved. Using whole&#x02010;genome sequencing, we identified two <italic toggle="no">TH</italic> variants in a young DRD patient, including a novel deep intronic variant. Minigene assays confirmed that this variant causes aberrant splicing. The patient exhibited an atypical disease progression compared with typical TH&#x02010;associated DRD cases, presenting with generalized dystonia, episodic hypotonia, Parkinsonism, and oromandibular dyskinesias. These findings, including the first known documented deep intronic <italic toggle="no">TH</italic> variant, expand our understanding of TH&#x02010;associated DRD's phenotypic and genotypic spectrum, aiding clinical evaluation.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="acn370013-kwd-0001">deep intronic variant</kwd><kwd id="acn370013-kwd-0002">dopa&#x02010;responsive dystonia</kwd><kwd id="acn370013-kwd-0003"><italic toggle="no">TH</italic></kwd></kwd-group><counts><fig-count count="1"/><table-count count="0"/><page-count count="4"/><word-count count="3000"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.6 mode:remove_FC converted:21.05.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="acn370013-ntgp-0001"><fn fn-type="funding" id="acn370013-note-0001"><p>
<bold>Funding:</bold> The authors received no specific funding for this work.</p></fn><fn fn-type="equal" id="acn370013-note-0002"><p>Xiaosheng Zheng and Chenxin Ying shared first authors (with equal contributions).</p></fn></fn-group></notes></front><body id="acn370013-body-0001"><sec id="acn370013-sec-0001"><label>1</label><title>Introduction</title><p>Dopa&#x02010;responsive dystonia (DRD) encompasses a spectrum of rare, genetically and clinically diverse monogenic dystonias caused by variants in <italic toggle="yes">GCH1</italic>, <italic toggle="yes">TH</italic>, <italic toggle="yes">SPR</italic>, <italic toggle="yes">PTS</italic>, and <italic toggle="yes">QDPR</italic> genes. According to the DRD MDSGene review, clinical characteristics such as an early age of onset, robust response to levodopa, the presence of dystonia, and diurnal symptom fluctuations are indicative of DRD [<xref rid="acn370013-bib-0001" ref-type="bibr">1</xref>]. However, challenges in diagnosis arise with non&#x02010;GCH1 DRD patients who initially present symptoms like hypotonia, mimicking cerebral palsy, and other atypical presentations characterized by low rates of diurnal fluctuations and oculogyric crises. Indeed, diagnostic delays averaging 5&#x02009;years were common for DRD patients [<xref rid="acn370013-bib-0001" ref-type="bibr">1</xref>]. Nearly all patients with delayed diagnosis are ultimately identified using molecular genetic methods [<xref rid="acn370013-bib-0002" ref-type="bibr">2</xref>, <xref rid="acn370013-bib-0003" ref-type="bibr">3</xref>], yet up to 20% of DRD patients test negative for pathogenic variants in the primary genes [<xref rid="acn370013-bib-0004" ref-type="bibr">4</xref>].</p><p>In our investigation, we detailed the disease progression of a TH&#x02010;associated DRD patient, accompanied by two newly documented phenotypes: episodic hypotonia and oromandibular dyskinesias. Furthermore, we identified and functionally characterized the first deep intronic variant in the <italic toggle="yes">TH</italic> gene, confirming its pathogenicity. These findings expand both our phenotypic and genotypic understanding of TH&#x02010;associated DRD, aiding future clinical evaluations of DRD patients.</p></sec><sec sec-type="materials-and-methods" id="acn370013-sec-0002"><label>2</label><title>Materials and Methods</title><sec id="acn370013-sec-0003"><label>2.1</label><title>Subjects and Genetic Study</title><p>Participants from the family were recruited from the Department of Neurology at Zhejiang University's Second Affiliated Hospital, and were examined face to face by at least two movement disorder specialists using established criteria [<xref rid="acn370013-bib-0001" ref-type="bibr">1</xref>]. The study received approval from the Ethics Committee of the Zhejiang University's Second Affiliated Hospital. The proband (II:1 in Figure&#x000a0;<xref rid="acn370013-fig-0001" ref-type="fig">1A</xref>) underwent whole&#x02010;genome sequencing (WGS) at our institution, which was processed via our in&#x02010;house pipeline (see <xref rid="acn370013-supitem-0001" ref-type="supplementary-material">Supporting Information Methods</xref>). All variants of genes related to dystonia and Parkinsonism were filtered with allele frequencies &#x02264;&#x02009;0.01. SpliceAI was utilized to predict aberrant splicing in the intronic regions of genes [<xref rid="acn370013-bib-0005" ref-type="bibr">5</xref>]. Manta was applied to detect structural variations in the WGS data.</p><fig position="float" fig-type="FIGURE" id="acn370013-fig-0001"><label>FIGURE 1</label><caption><p>Family pedigree and genetic analyses. (A) Pedigree of the family: The proband (II:1) was identified as a compound heterozygous carrier of <italic toggle="yes">TH</italic> variants&#x02014;Var1: c.487+118G&#x0003e;A and Var2: c.605G&#x0003e;A. Affected and unaffected family members are distinguished accordingly. (B) Sanger sequencing: Displays the sequencing chromatograms for <italic toggle="yes">TH</italic> variants. The left panel depicts Var1 (c.487+118G&#x0003e;A) observed in individuals I:1, II:1, and II:2, while the right panel shows Var2 (c.605G&#x0003e;A) found in individuals I:2 and II:1. (C) Splice site structure: Minigene assay demonstrates that the c.487+118G&#x0003e;A variant results in exon 3 skipping and intron 3 retention, generating a premature termination codon and a truncated protein. (D) Sanger Sequencing Results of RT&#x02010;PCR Products for the pcDNA3.1 Minigene Vector in HEK293T cells: The wild&#x02010;type transcript shows normal splicing across Exon 2 (222&#x02009;bp), Exon 3 (175&#x02009;bp), and Exon 4 (89&#x02009;bp). The mutant transcript demonstrates aberrant splicing with exon 3 omission and a 192&#x02009;bp inclusion from intron 3, resulting in a spliced product of Exon 2 (222&#x02009;bp), &#x025bd;intron3 (192&#x02009;bp), and Exon 4 (89&#x02009;bp).</p></caption><graphic xlink:href="ACN3-12-1093-g001" position="anchor" id="jats-graphic-1"/></fig></sec><sec id="acn370013-sec-0004"><label>2.2</label><title>Minigene&#x02010;Based Splice Assay</title><p>The impact of the deep intronic <italic toggle="yes">TH</italic> variant (c.487+118G&#x0003e;A) was evaluated in&#x000a0;vitro using minigene&#x02010;based splicing assays. Constructs of both wild&#x02010;type and mutant alleles were employed, as previously described [<xref rid="acn370013-bib-0006" ref-type="bibr">6</xref>]. Wild&#x02010;type and mutant minigenes were constructed using pcMINI&#x02010;C and pcDNA3.1 vectors. The minigene vectors for the deep intronic variant included either the complete intron or a segment of the intron adjacent to its exons (Figure&#x000a0;<xref rid="acn370013-supitem-0001" ref-type="supplementary-material">S1</xref>). Mutant vectors specific for c.487+118G&#x0003e;A were constructed using DNA from patients. Details of nucleotide primers are provided in Table&#x000a0;<xref rid="acn370013-supitem-0001" ref-type="supplementary-material">S1</xref>. Both wild&#x02010;type and mutant vectors were independently transfected into HeLa and HEK293T cells. After 48&#x02009;h, transfected cells were harvested using trypsin. Total RNA was then extracted and analyzed by RT&#x02010;PCR and gel electrophoresis. Each band of interest was subsequently sequenced using Sanger sequencing.</p></sec></sec><sec sec-type="results" id="acn370013-sec-0005"><label>3</label><title>Results</title><sec id="acn370013-sec-0006"><label>3.1</label><title>Clinical Finding of the Patient</title><p>The proband (II:1) was a 16&#x02010;year&#x02010;old Chinese adolescent with generalized dystonia, episodic hypotonia of the neck, and very mild Parkinsonism. His early developmental milestones were normal. At the age of 2&#x02013;3&#x02009;years, he began exhibiting unstable standing. Between the ages of 3 and 4, he developed right leg dystonia, resulting in an abnormal gait. By the age of 6, he experienced episodic hypotonia of the neck presenting like backward arching of the head when fatigued after intense play, requiring rest to recover. These symptoms demonstrated diurnal fluctuations. At the age of 8, dystonia had extended to all four limbs, causing walking difficulties and writing cramps. Subsequently, he was admitted to a movement disorder clinic and diagnosed with episodic dystonia. Treatment with levodopa (50&#x02009;mg) led to a dramatic improvement; his episodic hypotonia disappeared, and his walking and writing abilities improved, confirming a diagnosis of DRD. Genetic testing at the age of 10 using a dystonia gene panel (<xref rid="acn370013-supitem-0001" ref-type="supplementary-material">Supporting Information Methods</xref>) from another institute revealed a heterozygous variant in the <italic toggle="yes">TH</italic> gene (c.605G&#x0003e;A, p.Arg202His). This variant has been reported several times in DRD patients and is classified as likely pathogenic according to the ACMG guidelines (PS3&#x02010;strong+PM2&#x02010;supporting+PP1&#x02010;supporting+PP3&#x02010;supporting +PP4&#x02010;supporting) [<xref rid="acn370013-bib-0007" ref-type="bibr">7</xref>].</p><p>Upon his first visit to our clinic at the age of 16, while on levodopa, he displayed mild right&#x02010;sided body dystonia and very subtle bradykinesia in all four limbs (Video&#x000a0;<xref rid="acn370013-supitem-0002" ref-type="supplementary-material">S1</xref>, Segments 1&#x02013;2). He also presented with oromandibular dyskinesias, affecting the lower face, mouth, and jaw (Video&#x000a0;<xref rid="acn370013-supitem-0002" ref-type="supplementary-material">S1</xref>, Segments 1&#x02013;2). No abnormal eye movements or spasticity were observed. He reported no sleep disorders, cognitive decline, or autonomic symptoms. Dystonia would worsen and neck hypotonia would appear if he felt tired or stayed up very late. He could not recall the exact timing of the onset of oromandibular dyskinesias but reported that they did not improve greatly with levodopa. To differentiate drug&#x02010;related dyskinesias and confirm the uncommon neck hypotonia, we assessed the patient before and after the administration of medication during the most recent follow&#x02010;up visit (Video&#x000a0;<xref rid="acn370013-supitem-0002" ref-type="supplementary-material">S1</xref>, Segments 3&#x02013;5). Oromandibular dyskinesias were present both before and after medication with no major changes, confirming the presence of baseline dyskinesias in the patient. Moreover, before medication, the patient was unable to keep his head still, presenting with backward arching of his neck. A physical examination revealed decreased muscle tone in the neck (Video&#x000a0;<xref rid="acn370013-supitem-0002" ref-type="supplementary-material">S1</xref>, Segment 4), which completely resolved after levodopa administration.</p></sec><sec id="acn370013-sec-0007"><label>3.2</label><title>Detection and Functional Analysis of Deep Intronic Variant in <styled-content style="fixed-case" toggle="no">
<italic toggle="no">TH</italic>
</styled-content> Gene</title><p>Considering that the previous dystonia panel did not include structural variations of <italic toggle="yes">GCH1</italic> and <italic toggle="yes">TH</italic> and did not exclude variants related to Parkinsonism, we performed WGS to conduct a more detailed investigation. None of the variants were detected except for two variants in the <italic toggle="yes">TH</italic> gene. One was the aforementioned missense variant (c.605G&#x0003e;A, p.Arg202His), and the other was a novel deep intronic variant (c.487+118G&#x0003e;A). The deep intronic variant was rare in the population (0.0000157 from gnomAD) and was predicted to affect the splice site by SpliceAI (&#x00394;score&#x02009;=&#x02009;0.91). Familial segregation analysis showed that the c.605G&#x0003e;A variant (p.Arg202His) was inherited from his mother (I:2 in Figure&#x000a0;<xref rid="acn370013-fig-0001" ref-type="fig">1A</xref>) and the c.487+118G&#x0003e;A variant from his father (I:1 in Figure&#x000a0;<xref rid="acn370013-fig-0001" ref-type="fig">1A</xref>), while his healthy 7&#x02010;year&#x02010;old sister (II:2 in Figure&#x000a0;<xref rid="acn370013-fig-0001" ref-type="fig">1A</xref>) only carried a heterozygous variant of c.487+118G&#x0003e;A (Figure&#x000a0;<xref rid="acn370013-fig-0001" ref-type="fig">1B</xref>). This result confirmed that the proband was a compound heterozygous carrier of these two <italic toggle="yes">TH</italic> variants.</p><p>Expression level of <italic toggle="yes">TH</italic> gene was observed to be extremely low in whole blood. Therefore, a minigene splice assay was conducted to assess the impact of the c.487+118G&#x0003e;A variant on transcript splicing. RT&#x02010;PCR products from both wild&#x02010;type and mutant vectors in HeLa and HEK293T cells were examined on gel electrophoresis, indicating bands from mutant vectors were subtly longer than those of wild&#x02010;type vectors (Figure&#x000a0;<xref rid="acn370013-supitem-0001" ref-type="supplementary-material">S2</xref>). Sanger sequencing of RT&#x02010;PCR products from mutant vectors demonstrated an aberrant splice isoform of <italic toggle="yes">TH</italic> with exon 3 skipping and partial retention of intron 3 (Figures&#x000a0;<xref rid="acn370013-fig-0001" ref-type="fig">1C,D</xref> and <xref rid="acn370013-supitem-0001" ref-type="supplementary-material">S3</xref>). The retained intron generated a premature termination codon, resulting in a truncated protein of 141 amino acids (<xref rid="acn370013-supitem-0001" ref-type="supplementary-material">Supporting Information Results</xref>). Consequently, the c.487+118G&#x0003e;A variant was classified as pathogenic according to ACMG guidelines (PVS1&#x02010;very strong+PM2&#x02010;supporting+PP3&#x02010;supporting+PP4&#x02010;supporting). The patient was finally genetically diagnosed with DRD, caused by pathogenic compound heterozygous <italic toggle="yes">TH</italic> variants, and continued to respond well to levodopa treatment.</p></sec></sec><sec sec-type="discussion" id="acn370013-sec-0008"><label>4</label><title>Discussion</title><p>DRD is a complex disease with a wide range of phenotypic variability, making it difficult to recognize clinically and often leading to missed diagnoses. Specific symptoms may delineate DRD subtypes; for instance, autonomic disturbances are common in TH&#x02010; and PTS&#x02010;associated DRD, whereas sleep disturbances and oculogyric crises are more characteristic of SPR&#x02010;associated DRD [<xref rid="acn370013-bib-0001" ref-type="bibr">1</xref>]. Typically, TH&#x02010;associated DRD patients first develop hypotonia, followed by dystonia, and approximately 36% of these patients later exhibit Parkinsonism [<xref rid="acn370013-bib-0001" ref-type="bibr">1</xref>]. However, our patient's progression deviated significantly from this pattern, as he initially presented with dystonia, followed by episodic hypotonia, and subsequently oromandibular dyskinesias and Parkinsonism, without manifestation of the specific signs observed. This finding highlights the potential complexity and variability of initial presentations and disease progression in TH&#x02010;associated DRD. This complexity may be attributed to the presence of the novel deep intronic variant, though further data collection and analysis are required to confirm this.</p><p>To our knowledge, this study is the first to report two new phenomena in TH&#x02010;associated DRD: episodic hypotonia of the neck and oromandibular dyskinesias. Typically, DRD&#x02010;associated hypotonia presents as axial hypotonia responsive to levodopa treatment [<xref rid="acn370013-bib-0008" ref-type="bibr">8</xref>]. In our case, episodic hypotonia predominantly occurred in the neck, typically following strenuous activity or sleep deprivation, and responded well to levodopa. This is consistent with the typical response of axial hypotonia in DRD patients and confirms it as a symptom of TH&#x02010;associated DRD. Previously, mild dyskinesias were frequently observed in DRD patients on higher doses of levodopa compared with non&#x02010;dyskinetic DRD patients [<xref rid="acn370013-bib-0009" ref-type="bibr">9</xref>]. These dyskinesias resolved upon the reduction or discontinuation of medication [<xref rid="acn370013-bib-0010" ref-type="bibr">10</xref>]. However, the oromandibular dyskinesias observed in our patient persisted both before and after levodopa treatment, which has not previously been reported in DRD patients. This baseline dyskinesia may be linked to the underlying <italic toggle="yes">TH</italic> deficiency, but further case reports and mechanistic studies are needed to clarify this relationship. Therefore, future assessments of episodic hypotonia and oromandibular dyskinesias in TH&#x02010;associated DRD patients may be warranted, and these symptoms might even be considered potential indicators of TH&#x02010;associated DRD.</p><p>Most reported splice site <italic toggle="yes">TH</italic> variants were located at canonical splice sites, with only two reports of non&#x02010;canonical splice site variants (c.1201&#x02010;24T&#x0003e;A and c.645&#x02010;34C&#x0003e;A) identified through Sanger sequencing [<xref rid="acn370013-bib-0011" ref-type="bibr">11</xref>, <xref rid="acn370013-bib-0012" ref-type="bibr">12</xref>]. Due to the low expression of the <italic toggle="yes">TH</italic> gene in blood, only one study confirmed aberrant splicing using RNA isolated from cultured fibroblasts for c.1201&#x02010;24T&#x0003e;A. Advances in sequencing technology have highlighted deep intronic variants as potential key factors in uncovering the &#x0201c;missing heritability&#x0201d; of neurological diseases [<xref rid="acn370013-bib-0013" ref-type="bibr">13</xref>]. For DRD&#x02010;associated genes, a single study reported a homozygous deep intronic variant (c.541+347A&#x0003e;G) in the <italic toggle="yes">GCH1</italic> gene [<xref rid="acn370013-bib-0014" ref-type="bibr">14</xref>]. This variant, not listed in the gnomAD dataset, was predicted to have minimal impact on splicing events, requiring further functional analysis to establish its pathogenicity. In the present case, we used a minigene assay to confirm that this deep intronic <italic toggle="yes">TH</italic> variant results in a truncated protein of 141 amino acids, aligning with the characteristics of <italic toggle="yes">TH</italic> gene loss of function [<xref rid="acn370013-bib-0015" ref-type="bibr">15</xref>], thus broadening the genetic landscape of TH&#x02010;associated DRD and enhancing its clinical interpretation.</p></sec><sec id="acn370013-sec-0011"><title>Author Contributions</title><p>
<bold>Xiaosheng Zheng:</bold> study design, execution, statistical analysis, writing of the first draft, editing of the manuscript. <bold>Chenxin Ying:</bold> study design, execution, writing of the first draft, editing of the manuscript. <bold>Nan Jin:</bold> study execution, editing of the manuscript. <bold>Jinghong Ma:</bold> study execution, statistical analysis, editing of the manuscript. <bold>Xinhua Wan:</bold> study execution, editing of the manuscript. <bold>Xunhua Li:</bold> study design, editing of the manuscript. <bold>Wei Luo:</bold> study design, execution, statistical analysis, writing of the first draft, editing of the manuscript.</p></sec><sec sec-type="COI-statement" id="acn370013-sec-0009"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="acn370013-supitem-0001" position="float" content-type="local-data"><caption><p>
<bold>Figure S1.</bold> Schematic of the pcMINI&#x02010;C and pcDNA3.1 minigene vectors.</p><p>
<bold>FIGURE S2</bold>. Agarose gel electrophoresis of RT&#x02010;PCR products.</p><p>
<bold>FIGURE S3</bold>. Analysis of the remaining RT&#x02010;PCR products through Sanger sequencing from minigene vectors.</p><p>
<bold>TABLE S1</bold>. Nucleotide primers for mutagenesis, amplification of mutant vectors, and restriction endonuclease.</p></caption><media xlink:href="ACN3-12-1093-s001.docx"/></supplementary-material><supplementary-material id="acn370013-supitem-0002" position="float" content-type="local-data"><caption><p>
<bold>Video S1.</bold> Segments 1 and 2 were recorded during the patient&#x02019;s first visit to our clinic while on levodopa treatment. Segments 3, 4, and 5 were recorded during the most recent follow&#x02010;up visit, with Segments 3 and 4 captured before levodopa administration and Segment 5 after taking levodopa. Segment 1: This segment displays the proband performing finger tapping and toe tapping exercises, illustrating bradykinesia in all four limbs. Additionally, there is subtle right&#x02010;sided body dystonia and oromandibular dyskinesias evident during the movements. The patient shows subtle dyskinesias of the fingers when performing tasks with the opposite hand. Segment 2: This segment shows the patient walking, highlighting an extremely subtle dystonic gait in the lower limbs, indicative of mild muscle tone disturbances. Segment 3: Before levodopa administration, the proband performs finger tapping and toe tapping exercises, revealing obvious bradykinesia in all four limbs, neck retroflexion, and oromandibular dyskinesias. Segment 4: Prior to levodopa treatment, decreased neck muscle tone is evident, with the patient unable to maintain an upright position, leading to him falling backward or forward. Segment 5: After levodopa administration, the patient&#x02019;s limb movements show significant improvement compared to the pre&#x02010;treatment state, and he can maintain a normal neck posture.</p></caption><media xlink:href="ACN3-12-1093-s002.mp4" mimetype="video" mime-subtype="mp4"/></supplementary-material></sec></body><back><ack id="acn370013-sec-0010"><title>Acknowledgments</title><p>We appreciate the efforts of all the authors for this article. We thank Sarah Williams, PhD, from Liwen Bianji (Edanz) (<ext-link xlink:href="http://www.liwenbianji.cn/" ext-link-type="uri">www.liwenbianji.cn/</ext-link>) for editing the English text of this manuscript.</p></ack><sec sec-type="data-availability" id="acn370013-sec-0013"><title>Data Availability Statement</title><p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></sec><ref-list content-type="cited-references" id="acn370013-bibl-0001"><title>References</title><ref id="acn370013-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="acn370013-cit-0001">
<string-name>
<given-names>A.</given-names>
<surname>Weissbach</surname>
</string-name>, <string-name>
<given-names>M. G.</given-names>
<surname>Pauly</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Herzog</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Relationship of Genotype, Phenotype, and Treatment in Dopa&#x02010;Responsive Dystonia: MDSGene Review</article-title>,&#x0201d; <source>Movement Disorders</source>
<volume>37</volume>, no. <issue>2</issue> (<year>2022</year>): <fpage>237</fpage>&#x02013;<lpage>252</lpage>.<pub-id pub-id-type="pmid">34908184</pub-id>
</mixed-citation></ref><ref id="acn370013-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="acn370013-cit-0002">
<string-name>
<given-names>T. B.</given-names>
<surname>Ahn</surname>
</string-name>, <string-name>
<given-names>S. J.</given-names>
<surname>Chung</surname>
</string-name>, <string-name>
<given-names>S. B.</given-names>
<surname>Koh</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Residual Signs of Dopa&#x02010;Responsive Dystonia With GCH1 Variant Following Levodopa Treatment Are Uncommon in Korean Patients</article-title>,&#x0201d; <source>Parkinsonism &#x00026; Related Disorders</source>
<volume>65</volume> (<year>2019</year>): <fpage>248</fpage>&#x02013;<lpage>251</lpage>.<pub-id pub-id-type="pmid">31213404</pub-id>
</mixed-citation></ref><ref id="acn370013-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="acn370013-cit-0003">
<string-name>
<given-names>S. I.</given-names>
<surname>Berger</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Miller</surname>
</string-name>, and <string-name>
<given-names>L.</given-names>
<surname>Tochen</surname>
</string-name>, &#x0201c;<article-title>Recessive GCH1 Deficiency Causing DOPA&#x02010;Responsive Dystonia Diagnosed by Reported Negative Exome</article-title>,&#x0201d; <source>Pediatrics</source>
<volume>149</volume>, no. <issue>2</issue> (<year>2022</year>): <elocation-id>e2021052886</elocation-id>, <pub-id pub-id-type="doi">10.1542/peds.2021-052886</pub-id>.<pub-id pub-id-type="pmid">35083481</pub-id>
</mixed-citation></ref><ref id="acn370013-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="acn370013-cit-0004">
<string-name>
<given-names>F.</given-names>
<surname>Clot</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Grabli</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Cazeneuve</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Exhaustive Analysis of BH4 and Dopamine Biosynthesis Genes in Patients With Dopa&#x02010;Responsive Dystonia</article-title>,&#x0201d; <source>Brain</source>
<volume>132</volume>, no. <issue>Pt 7</issue> (<year>2009</year>): <fpage>1753</fpage>&#x02013;<lpage>1763</lpage>, <pub-id pub-id-type="doi">10.1093/brain/awp084</pub-id>.<pub-id pub-id-type="pmid">19491146</pub-id>
</mixed-citation></ref><ref id="acn370013-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="acn370013-cit-0005">
<string-name>
<given-names>K.</given-names>
<surname>Jaganathan</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Kyriazopoulou Panagiotopoulou</surname>
</string-name>, <string-name>
<given-names>J. F.</given-names>
<surname>McRae</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Predicting Splicing From Primary Sequence With Deep Learning</article-title>,&#x0201d; <source>Cell</source>
<volume>176</volume>, no. <issue>3</issue> (<year>2019</year>): <fpage>535</fpage>&#x02013;<lpage>548</lpage>.e24.<pub-id pub-id-type="pmid">30661751</pub-id>
</mixed-citation></ref><ref id="acn370013-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="acn370013-cit-0006">
<string-name>
<given-names>X.</given-names>
<surname>Luo</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Sun</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Deep Intronic PAH Variants Explain Missing Heritability in Hyperphenylalaninemia</article-title>,&#x0201d; <source>Journal of Molecular Diagnostics</source>
<volume>25</volume>, no. <issue>5</issue> (<year>2023</year>): <fpage>284</fpage>&#x02013;<lpage>294</lpage>.</mixed-citation></ref><ref id="acn370013-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="acn370013-cit-0007">
<string-name>
<given-names>S.</given-names>
<surname>Richards</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Aziz</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Bale</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>,&#x0201d; <source>Genetics in Medicine</source>
<volume>17</volume>, no. <issue>5</issue> (<year>2015</year>): <fpage>405</fpage>&#x02013;<lpage>424</lpage>.<pub-id pub-id-type="pmid">25741868</pub-id>
</mixed-citation></ref><ref id="acn370013-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="acn370013-cit-0008">
<string-name>
<given-names>W. W.</given-names>
<surname>Lee</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Jeon</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Kim</surname>
</string-name>, &#x0201c;<article-title>Expanding the Spectrum of Dopa&#x02010;Responsive Dystonia (DRD) and Proposal for New Definition: DRD, DRD&#x02010;Plus, and DRD Look&#x02010;Alike</article-title>,&#x0201d; <source>Journal of Korean Medical Science</source>
<volume>33</volume>, no. <issue>28</issue> (<year>2018</year>): <elocation-id>e184</elocation-id>.<pub-id pub-id-type="pmid">29983692</pub-id>
</mixed-citation></ref><ref id="acn370013-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="acn370013-cit-0009">
<string-name>
<given-names>W. J.</given-names>
<surname>Hwang</surname>
</string-name>, <string-name>
<given-names>D. B.</given-names>
<surname>Calne</surname>
</string-name>, <string-name>
<given-names>J. K.</given-names>
<surname>Tsui</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>de la Fuente&#x02010;Fern&#x000e1;ndez</surname>
</string-name>, &#x0201c;<article-title>The Long&#x02010;Term Response to Levodopa in Dopa&#x02010;Responsive Dystonia</article-title>,&#x0201d; <source>Parkinsonism &#x00026; Related Disorders</source>
<volume>8</volume>, no. <issue>1</issue> (<year>2001</year>): <fpage>1</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">11472874</pub-id>
</mixed-citation></ref><ref id="acn370013-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="acn370013-cit-0010">
<string-name>
<given-names>R.</given-names>
<surname>Pons</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Syrengelas</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Youroukos</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Levodopa&#x02010;Induced Dyskinesias in Tyrosine Hydroxylase Deficiency</article-title>,&#x0201d; <source>Movement Disorders</source>
<volume>28</volume>, no. <issue>8</issue> (<year>2013</year>): <fpage>1058</fpage>&#x02013;<lpage>1063</lpage>.<pub-id pub-id-type="pmid">23389938</pub-id>
</mixed-citation></ref><ref id="acn370013-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="acn370013-cit-0011">
<string-name>
<given-names>R. J.</given-names>
<surname>Janssen</surname>
</string-name>, <string-name>
<given-names>R. A.</given-names>
<surname>Wevers</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>H&#x000e4;ussler</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>A Branch Site Variant Leading to Aberrant Splicing of the Human Tyrosine Hydroxylase Gene in a Child With a Severe Extrapyramidal Movement Disorder</article-title>,&#x0201d; <source>Annals of Human Genetics</source>
<volume>64</volume>, no. <issue>Pt 5</issue> (<year>2000</year>): <fpage>375</fpage>&#x02013;<lpage>382</lpage>.<pub-id pub-id-type="pmid">11281275</pub-id>
</mixed-citation></ref><ref id="acn370013-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="acn370013-cit-0012">
<string-name>
<given-names>W.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Zhou</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Li</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Dopa&#x02010;Responsive Dystonia in Chinese Patients: Including a Novel Heterozygous Variant in the GCH1 Gene With an Intermediate Phenotype and One Case of Prenatal Diagnosis</article-title>,&#x0201d; <source>Neuroscience Letters</source>
<volume>644</volume> (<year>2017</year>): <fpage>48</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">28087438</pub-id>
</mixed-citation></ref><ref id="acn370013-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="acn370013-cit-0013">
<string-name>
<given-names>M. H.</given-names>
<surname>Wojcik</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Lemire</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Berger</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Genome Sequencing for Diagnosing Rare Diseases</article-title>,&#x0201d; <source>New England Journal of Medicine</source>
<volume>390</volume>, no. <issue>21</issue> (<year>2024</year>): <fpage>1985</fpage>&#x02013;<lpage>1997</lpage>.<pub-id pub-id-type="pmid">38838312</pub-id>
</mixed-citation></ref><ref id="acn370013-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="acn370013-cit-0014">
<string-name>
<given-names>H.</given-names>
<surname>Stranneheim</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Lagerstedt&#x02010;Robinson</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Magnusson</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Integration of Whole Genome Sequencing Into a Healthcare Setting: High Diagnostic Rates Across Multiple Clinical Entities in 3219 Rare Disease Patients</article-title>,&#x0201d; <source>Genome Medicine</source>
<volume>13</volume>, no. <issue>1</issue> (<year>2021</year>): <elocation-id>40</elocation-id>.<pub-id pub-id-type="pmid">33726816</pub-id>
</mixed-citation></ref><ref id="acn370013-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="acn370013-cit-0015">
<string-name>
<given-names>S. J.</given-names>
<surname>Rose</surname>
</string-name>, <string-name>
<given-names>X. Y.</given-names>
<surname>Yu</surname>
</string-name>, <string-name>
<given-names>A. K.</given-names>
<surname>Heinzer</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>A New Knock&#x02010;In Mouse Model of l&#x02010;DOPA&#x02010;Responsive Dystonia</article-title>,&#x0201d; <source>Brain</source>
<volume>138</volume>, no. <issue>Pt 10</issue> (<year>2015</year>): <fpage>2987</fpage>&#x02013;<lpage>3002</lpage>, <pub-id pub-id-type="doi">10.1093/brain/awv212</pub-id>.<pub-id pub-id-type="pmid">26220941</pub-id>
</mixed-citation></ref></ref-list></back></article>